Citation Impact
Citing Papers
Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery
2009
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
2011
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
The epidemiology of venous thromboembolism
2016
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
2013
Effect of hypertension on anticoagulated patients with atrial fibrillation
2007
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Factors at Admission Associated With Bleeding Risk in Medical Patients
2010
Choice of Prosthetic Heart Valve in Adults
2010
Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience
2010
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up
2012 StandoutNobel
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
2014
Oral Anticoagulant Therapy
2012 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Chronic thromboembolic pulmonary hypertension
2018
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)
2008
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
2011 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
2010
B vitamins in stroke prevention: time to reconsider
2017
Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study
2012
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Additional causes for distal sensory polyneuropathy in diabetic patients
2005
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Atrial fibrillation
2011
Antihypertensive treatment can prevent stroke and cognitive decline
2012
Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment
2006
Molecular Biology of Chronic Thromboembolic Pulmonary Hypertension
2006
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
The Perioperative Management of Antithrombotic Therapy
2008
D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence
2017
Effect of Study Setting on Anticoagulation Control
2006
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
Nutrition and the risk of stroke
2011
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients
2013
Causes of elevated D-dimer in patients admitted to a large urban emergency department
2013
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Antithrombotic Therapy for Atrial Fibrillation
2012
Chronic thromboembolic pulmonary hypertension
2014
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Risk factors for venous thrombosis – current understanding from an epidemiological point of view
2010
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
2017
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Prediction of venous thromboembolism in cancer patients
2010
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
2011
Works of Daniela Poli being referenced
Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation
2005
The negative predictive value of D‐dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: A prospective cohort study (the PROLONG PLUS study)
2012
Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis
2006
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics
2007
Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years
2009
Assessing recurrence risk following acute venous thromboembolism
2013
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
2010
Fibrin Resistance to Lysis in Patients with Pulmonary Hypertension Other Than Thromboembolic
2010
Risks factors for highly unstable response to oral anticoagulation: a case‐control study
2005
Hyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation?
2004
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
2012
Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic
2003
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism
2010
Gender differences of bleeding and stroke risk in very Old atrial fibrillation patients on VKA treatment
2012
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score
2007
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
2011
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
2009
Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension
2010
Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment
2011
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
2003
Stroke Risk Stratification in a “Real-World” Elderly Anticoagulated Atrial Fibrillation Population
2010
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
2014
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d -Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism
2010